Efficacy and safety of albendazole 400 mg for 30 days compared to single dose of ivermectin in adult patients with low Loa loa microfilaremia: A non-inferiority randomized controlled trial.

Efficacy and safety of albendazole 400 mg for 30 days compared to single dose of ivermectin in adult patients with low Loa loa microfilaremia: A non-inferiority randomized controlled trial.

<h4>Background</h4>Loa loa infection is endemic in central African countries and particularly in Gabon. Treatment typically involves the use of ivermectin and albendazole, with albendazole often administered to reduce microfilaremia in individuals with high microfilaremia before taking i...

Full description

Saved in:
Bibliographic Details
Main Authors: Luccheri Ndong Akomezoghe, Noé Patrick M'Bondoukwé, Denise Patricia Mawili Mboumba, Jacques Mari Ndong Ngomo, Bridy Chesly Moutombi Ditombi, Coella Joyce Mihindou, Roger Hadry Sibi Matotou, Valentin Migueba, Marielle Karine Bouyou Akotet
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-06-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://doi.org/10.1371/journal.pntd.0012383
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1371/journal.pntd.0012383

Similar Items